Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 1.35% is 61% below its 5-year average of 3.48%, around the middle of its 5-year range (-7.31%–7.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 441.30% above its 12-month average of -0.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.35%.
RETURN ON INVESTED CAPITAL (ROIC)
1.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-0.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
0.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
3.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
0.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+441.30%
CURRENT VS 3Y AVG
+2476.74%
CURRENT VS 5Y AVG
-61.13%
CURRENT VS 10Y AVG
+241.17%
CURRENT VS 15Y AVG
+2314.89%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.27%
median of 715 covered companies
CURRENT VS SECTOR MEDIAN
+104.06%
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$984.16M
Return on Invested Capital (ROIC)
1.35%
TTM Avg
-0.40%
3Y Avg
0.05%
5Y Avg
3.48%
Market Cap
$987.92M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$991.26M
Return on Invested Capital (ROIC)
52.81%
TTM Avg
-75.45%
3Y Avg
-63.24%
5Y Avg
-50.31%
Market Cap
$993.23M
Return on Invested Capital (ROIC)
-27.51%
TTM Avg
-21.69%
3Y Avg
-25.73%
5Y Avg
-26.71%
Market Cap
$999.27M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-132.46%
3Y Avg
-76.17%
5Y Avg
-76.17%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$951.66M
Return on Invested Capital (ROIC)
-67.13%
TTM Avg
-38.55%
3Y Avg
-37.38%
5Y Avg
-31.65%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
0.86%
TTM Avg
2.66%
3Y Avg
2.26%
5Y Avg
2.26%
Market Cap
$946.97M
Return on Invested Capital (ROIC)
-50.77%
TTM Avg
-47.91%
3Y Avg
-50.09%
5Y Avg
-281.80%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $984.16M | 1.35% | -0.40% | 0.05% | 3.48% |
| Aktis Oncology, Inc. (AKTS)vs › | $987.92M | -16.54% | -24.45% | -23.43% | -23.43% |
| MeiraGTx Holdings plc (MGTX)vs › | $991.26M | 52.81% | -75.45% | -63.24% | -50.31% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $993.23M | -27.51% | -21.69% | -25.73% | -26.71% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $999.27M | -28.14% | -132.46% | -76.17% | -76.17% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $951.66M | -67.13% | -38.55% | -37.38% | -31.65% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.86% | 2.66% | 2.26% | 2.26% |
| MoonLake Immunotherapeutics (MLTX)vs › | $946.97M | -50.77% | -47.91% | -50.09% | -281.80% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $938.53M | -66.23% | -66.23% | -66.23% | -66.23% |
ROIC
1.4%
ROE
2.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 1.35% |
| 2026-03-31 | 1.12% |
| 2025-12-31 | 0.96% |
| 2025-09-30 | 1.90% |
| 2025-06-30 | -7.31% |
| 2025-03-31 | -5.74% |
| 2024-12-31 | -5.08% |
| 2024-09-30 | -4.58% |
| 2024-06-30 | 3.76% |
| 2024-03-31 | 4.80% |
| 2023-12-31 | 4.01% |
| 2023-09-30 | 2.17% |
| 2023-06-30 | 3.32% |
| 2023-03-31 | 2.75% |
| 2022-12-31 | 3.83% |
| 2022-09-30 | 3.76% |
| 2022-06-30 | 4.27% |
| 2022-03-31 | 3.72% |
| 2021-12-31 | 3.47% |
| 2021-09-30 | 6.65% |
| 2021-06-30 | 7.25% |
| 2021-03-31 | 4.03% |
| 2020-12-31 | 3.96% |
| 2020-09-30 | 2.58% |
| 2020-06-30 | 1.77% |
| 2020-03-31 | 1.97% |
| 2019-12-31 | 1.45% |
| 2019-09-30 | 2.95% |
| 2019-06-30 | 3.22% |
| 2019-03-31 | 3.50% |
| 2018-12-31 | 2.53% |
| 2018-09-30 | 2.00% |
| 2018-06-30 | 0.76% |
| 2018-03-31 | -3.11% |
| 2017-12-31 | -4.36% |
| 2017-09-30 | -6.47% |
| 2017-06-30 | -9.69% |
| 2017-03-31 | -7.89% |
| 2016-12-31 | -9.24% |
| 2016-09-30 | -8.88% |
| 2016-06-30 | -1.23% |
| 2016-03-31 | 1.10% |
| 2015-12-31 | 3.48% |
| 2015-09-30 | 5.25% |
| 2015-06-30 | 3.62% |
| 2015-03-31 | 2.46% |
| 2014-12-31 | -2.78% |
| 2014-09-30 | -13.46% |
| 2014-06-30 | -13.18% |
| 2014-03-31 | -104.26% |
| 2013-12-31 | -111.30% |
| 2013-09-30 | -106.99% |
| 2013-06-30 | -38.25% |
| 2013-03-31 | -32.92% |
| 2012-12-31 | -50.36% |
| 2012-09-30 | -42.64% |
| 2012-06-30 | -32.29% |
| 2012-03-31 | -56.39% |
| 2011-12-31 | -44.13% |
| 2011-09-30 | -46.51% |
| 2011-06-30 | -37.30% |
| 2011-03-31 | -29.70% |
| 2010-12-31 | -41.88% |
| 2010-09-30 | -62.91% |
| 2010-06-30 | -66.96% |
